Publications by authors named "Matthew D Heath"

Claim this Profile
A
Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy.
Benjamin O Slusarenko, Klara F Borrmann, Claudia Knappe, Jonathan Vogel, Benjamin Schnautz, Matthew D Heath

J Investig Allergol Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study.
Janice A Layhadi, Sviatlana Starchenka, Pieter-Jan De Kam, Elizabeth Palmer, Lily Y D Wu, Matthew D Heath

Allergy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the role of antibody affinity and avidity in the IgE-mediated allergic response.
Martin F Bachmann, Pascal S Krenger, Mona O Mohsen, Matthias F Kramer, Sviatlana Starchenka, Matthew D Heath

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals.
Janice A Layhadi, Sviatlana Starchenka, Pieter-Jan De Kam, Elizabeth Palmer, Nandinee Patel, Matthew D Heath

J Allergy Clin Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy.
Pascal S Krenger, Romano Josi, Jan Sobczak, Thalia L C Velazquez, Ina Balke, Matthew D Heath

Allergy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex Vivo Immunomodulatory Effects of Lactobacillus-, Lacticaseibacillus-, and Bifidobacterium-Containing Synbiotics on Human Peripheral Blood Mononuclear Cells and Monocyte-Derived Dendritic Cells in the Context of Grass Pollen Allergy.
Alexander Heldner, Matthew D Heath, Benjamin Schnautz, Sebastian Kotz, Adam Chaker

Probiotics Antimicrob Proteins· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next generation virus-like particle platform for the treatment of peanut allergy.
Jan M Sobczak, Pascal S Krenger, Federico Storni, Mona O Mohsen, Ina Balke, Matthew D Heath

Allergy· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen Content of Therapeutic Preparations for Allergen-Specific Immunotherapy of European Paper Wasp Venom Allergy.
Johannes Grosch, Antoine Lesur, Stéphanie Kler, François Bernardin, Gunnar Dittmar, Matthew D Heath

Toxins (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Alexander Heldner, Francesca Alessandrini, Dennis Russkamp, Sonja Heine, Benjamin Schnautz, Matthew D Heath

Allergy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venom Immunotherapy: From Proteins to Product to Patient Protection.
Martin Feindor, Matthew D Heath, Simon J Hewings, Thalia L Carreno Velazquez, Simon Blank

Toxins (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
Pieter-Jan De Kam, Matthias F Kramer, Mohamed H Shamji, Kemi Oluwayi, Matthew D Heath

World Allergy Organ J· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT).
Matthew D Heath, Mona O Mohsen, Pieter-Jan de Kam, Thalia L Carreno Velazquez, Simon J Hewings

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens.
Federico Storni, Andris Zeltins, Ina Balke, Matthew D Heath, Matthias F Kramer

J Allergy Clin Immunol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination against Allergy: A Paradigm Shift?
Martin F Bachmann, Mona O Mohsen, Matthias F Kramer, Matthew D Heath

Trends Mol Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: -Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Infection. 2019, , 72.
Gustavo Cabral-Miranda, Stephanie M Lim, Mona O Mohsen, Ilya V Pobelov, Elisa S Roesti, Matthew D Heath

Vaccines (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Evaluation of PQ Birch Allergy Immunotherapy to Support Product Development.
Paul Baldrick, James W Hutchings, Matthew D Heath, Murray A Skinner

Regul Toxicol Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy.
Sviatlana Starchenka, Matthew D Heath, Alyson Lineberry, Tim Higenbottam, Murray A Skinner

World Allergy Organ J· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a high-speed video system for measuring saccadic eye movement.
Jeffrey S Brooks, William J Smith, Brandon M Webb, Matthew D Heath, James P Dickey

Behav Res Methods· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New toxicity testing of PQ grass allergy immunotherapy to support product development.
Paul Baldrick, James W Hutchings, Matthew D Heath, Murray A Skinner, Tom Martin

J Appl Toxicol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Infection.
Gustavo Cabral-Miranda, Stephanie M Lim, Mona O Mohsen, Ilya V Pobelov, Elisa S Roesti, Matthew D Heath

Vaccines (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
Mona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins

J Immunother Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
Mona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins

J Immunother Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.
Gustavo Cabral-Miranda, Ahmed M Salman, Mona O Mohsen, Federico L Storni, Elisa S Roesti, Matthew D Heath

Diseases· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.
Deborah S Leuthard, Agathe Duda, Sandra N Freiberger, Sina Weiss, Isabella Dommann, Matthew D Heath

J Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcrystalline Tyrosine (MCT): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.
Gustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, Mona O Mohsen, Eduardo Montoya-Diaz

Vaccines (Basel)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis